Eric A. Pierce
About
In The Last Decade
Eric A. Pierce
142 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Molecular Biology 6.0k
- Ophthalmology 3.1k
- Radiology, Nuclear Medicine and Imaging 1.9k
- Genetics 1.6k
- Cellular and Molecular Neuroscience 816
Countries citing papers authored by Eric A. Pierce
This map shows the geographic impact of Eric A. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Pierce more than expected).
Fields of papers citing papers by Eric A. Pierce
This network shows the impact of papers produced by Eric A. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Pierce. The network helps show where Eric A. Pierce may publish in the future.
Co-authorship network of co-authors of Eric A. Pierce
This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Pierce. A scholar is included among the top collaborators of Eric A. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Pierce. Eric A. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 18 | |
| 7 | AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: 2 year Results of an Ongoing Phase I/II Gene Therapy Trial | 5 |
| 8 | Subfoveal gene augmentation therapy for choroideremia: One-year results from a Phase I/II trial of AAV2-hCHM | 1 |
| 9 | The Effect Of Vitamin A On Progression Of Retinitis Pigmentosa Is Not Determined By The Underlying Genetic Cause Of Disease | 2 |
| 10 | Evaluation of in silico reconstructed ancestral adeno-associated virus for gene augmentation therapy in a mouse model of LCA | 1 |
| 11 | Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes. | 10 |
| 12 | Transcriptome analyses reveal minimal aberrant splicing in mouse models of RNA splicing factor retinitis pigmentosa | 1 |
| 13 | Adaptive Optics Scanning Laser Ophthalmoscopy and High Resolution Imaging in Autosomal Dominant Retinitis Pigmentosa Caused by a Novel PRPF31 Nonsense Mutation | 1 |
| 14 | Genome-Wide Linkage Analysis For Gene Discovery In Autosomal Dominant Retinitis Pigmentosa | 1 |
| 15 | 42 | |
| 16 | Characterization of Aberrant Splicing by Comparative Exon Microarray-Based Analysis in Mice With Targeted Mutations in Prpf3, Prpf8, and Prpf31 | 1 |
| 17 | Characterization of Compound Knockin Prpf3/Prpf8 Mice | 1 |
| 18 | Haploinsufficiency of Prpf8 Does Not Cause Retinal Degeneration | 2 |
| 19 | 49 | |
| 20 | 254 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.